• Profile
Close

Racial differences in treatment and survival among veterans and non-veterans with stage I NSCLC: An evaluation of Veterans Affairs (VA) and SEER-Medicare populations

Cancer Epidemiology, Biomarkers & Prevention Oct 23, 2019

Williams CD, Alpert N, Redding TS, et al. - Given that Stage I NSCLC is preferably managed surgically with radiation reserved for those not receiving surgery, and lower rates of surgery have been reported among Blacks with Stage I NSCLC vs among Whites in earlier studies, researchers evaluated the links between race, treatment and survival, using logistic regression and Cox proportional hazards models, among black and white men aged ≥ 65 years with stage I NSCLC diagnosed 2001-2009 and selected from the Surveillance, Epidemiology, and End Results (SEER)-Medicare database and Veterans Affairs (VA) cancer registry. Findings revealed that the likelihood of receiving surgical treatment was less in Blacks among VA and SEER-Medicare patients. When accounting for treatment, similar survival outcomes were reported among Blacks and Whites.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay